Showing results (1961-1970 of 2,093) with videos related to

Sort By:
Pageof 210
Blood|May 1, 1997
Recombinant methionyl human stem cell factor and filgrastim for peripheral blood progenitor cell mobilization and transplantation in non-Hodgkin's lymphoma patients--results of a phase I/II trialC H Moskowitz, P Stiff, M S Gordon, et al.
Nano Letters|September 11, 2013
Giant piezoresistive on/off ratios in rare-earth chalcogenide thin films enabling nanomechanical switchingM Copel, M A Kuroda, M S Gordon, et al.
The American Journal of Pathology|February 18, 1998
Activation of coagulation and angiogenesis in cancer: immunohistochemical localization in situ of clotting proteins and vascular endothelial growth factor in human cancerM Shoji, W W Hancock, K Abe, et al.
Cancer|October 4, 2019
Patient-reported outcomes and inflammatory biomarkers in patients with locally advanced/metastatic urothelial carcinoma treated with durvalumab in phase 1/2 dose-escalation study 1108Peter H O'Donnell, Hendrick Tobias Arkenau, Srikala S Sridhar, et al.
HIV Medicine|May 18, 2016
The impact of prescribed opioids on CD4 cell count recovery among HIV-infected patients newly initiating antiretroviral therapyE J Edelman, K S Gordon, J P Tate, et al.
Journal for Immunotherapy of Cancer|October 19, 2021
Avelumab for platinum-ineligible/refractory recurrent and/or metastatic squamous cell carcinoma of the head and neck: phase Ib results from the JAVELIN Solid Tumor trialJoël Guigay, Keun-Wook Lee, Manish R Patel, et al.
The Journal of Chemical Physics|July 27, 2023
Toward an extreme-scale electronic structure systemJorge L Galvez Vallejo, Calum Snowdon, Ryan Stocks, et al.
The American Journal of Cardiology|April 19, 2024
Kidney and Cardiovascular Effectiveness of Empagliflozin Compared With Dipeptidyl Peptidase-4 Inhibitors in Patients With Type 2 DiabetesDaniel Edmonston, Hillary Mulder, Elizabeth Lydon, et al.
Open Forum Infectious Diseases|July 14, 2022
Opaganib in Coronavirus Disease 2019 Pneumonia: Results of a Randomized, Placebo-Controlled Phase 2a TrialKevin L Winthrop, Alan W Skolnick, Adnan M Rafiq, et al.
JAMA Oncology|October 4, 2019
Response Rate Following Albumin-Bound Paclitaxel Plus Gemcitabine Plus Cisplatin Treatment Among Patients With Advanced Pancreatic Cancer: A Phase 1b/2 Pilot Clinical TrialGayle S Jameson, Erkut Borazanci, Hani M Babiker, et al.
Pageof 210